Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | lysine (K)-specific demethylase 4A | Starlite/ChEMBL | No references |
Homo sapiens | geminin, DNA replication inhibitor | Starlite/ChEMBL | No references |
Homo sapiens | GNAS complex locus | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Schistosoma mansoni | GTP-binding protein alpha subunit gna | GNAS complex locus | 394 aa | 450 aa | 28.7 % |
Brugia malayi | Hypothetical 65.5 kDa Trp-Asp repeats containing protein F02E8.5 inchromosome X | geminin, DNA replication inhibitor | 209 aa | 176 aa | 27.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0055 | 0.0569 | 0.0569 |
Echinococcus granulosus | lysine specific demethylase 5A | 0.0043 | 0.021 | 0.021 |
Brugia malayi | jmjC domain containing protein | 0.0043 | 0.021 | 0.021 |
Trypanosoma cruzi | diacylglycerol acyltransferase, putative | 0.0087 | 0.1463 | 0.5 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0055 | 0.0569 | 0.0569 |
Schistosoma mansoni | jumonji/arid domain-containing protein | 0.0043 | 0.021 | 0.021 |
Echinococcus multilocularis | geminin | 0.0205 | 0.4814 | 0.4814 |
Plasmodium vivax | hypothetical protein, conserved | 0.0035 | 0 | 0.5 |
Onchocerca volvulus | 0.0087 | 0.1463 | 1 | |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0055 | 0.0569 | 0.0569 |
Echinococcus multilocularis | Transcription factor, JmjC domain containing protein | 0.0115 | 0.2276 | 0.2276 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.0569 | 0.0569 |
Loa Loa (eye worm) | jmjC domain-containing protein | 0.0073 | 0.1065 | 0.1065 |
Trypanosoma brucei | diacylglycerol acyltransferase, putative | 0.0087 | 0.1463 | 0.5 |
Toxoplasma gondii | dgat2l1-prov protein | 0.0087 | 0.1463 | 1 |
Trypanosoma cruzi | diacylglycerol acyltransferase, putative | 0.0087 | 0.1463 | 0.5 |
Echinococcus granulosus | Transcription factor JmjC domain containing protein | 0.0115 | 0.2276 | 0.2276 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.0569 | 0.0569 |
Brugia malayi | diacylglycerol acyltransferase family protein | 0.0087 | 0.1463 | 0.1463 |
Echinococcus granulosus | alpha 16 mannosyl glycoprotein | 0.0387 | 1 | 1 |
Echinococcus granulosus | jumonji domain containing protein | 0.0049 | 0.0392 | 0.0392 |
Schistosoma mansoni | diacylglycerol O-acyltransferase 1 | 0.0087 | 0.1463 | 0.1463 |
Loa Loa (eye worm) | diacylglycerol acyltransferase | 0.0087 | 0.1463 | 0.1463 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0055 | 0.0569 | 0.0569 |
Giardia lamblia | PHD finger protein 15 | 0.0035 | 0 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 0.4814 | 0.4814 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0055 | 0.0569 | 0.0569 |
Loa Loa (eye worm) | jmjC domain-containing protein | 0.0043 | 0.021 | 0.021 |
Echinococcus multilocularis | jumonji domain containing protein | 0.0049 | 0.0392 | 0.0392 |
Plasmodium falciparum | phd finger protein, putative | 0.0035 | 0 | 0.5 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0055 | 0.0569 | 0.0569 |
Leishmania major | diacylglycerol acyltransferase, putative | 0.0087 | 0.1463 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 0.4814 | 0.4814 |
Schistosoma mansoni | jumonji/arid domain-containing protein | 0.0043 | 0.021 | 0.021 |
Loa Loa (eye worm) | hypothetical protein | 0.0387 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.0715 | 0.0715 |
Echinococcus granulosus | geminin | 0.0205 | 0.4814 | 0.4814 |
Schistosoma mansoni | beta-12-n-acetylglucosaminyltransferase II | 0.0387 | 1 | 1 |
Echinococcus multilocularis | lysine specific demethylase 5A | 0.0043 | 0.021 | 0.021 |
Schistosoma mansoni | jumonji domain containing protein | 0.0092 | 0.1603 | 0.1603 |
Brugia malayi | jmjC domain containing protein | 0.0115 | 0.2276 | 0.2276 |
Echinococcus multilocularis | alpha 1,6 mannosyl glycoprotein | 0.0387 | 1 | 1 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.0569 | 0.0569 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 0.2818 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b: Cytotox Counterscreen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588855, AID588860] | ChEMBL. | No reference |
Potency (functional) | 1 uM | PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 6.5131 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 10 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of JMJD2A-Tudor Domain. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504402] | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.